AstraZeneca announced it has established Evinova — a health-technology division dedicated to incorporating digital solutions and artificial intelligence into clinical trials. The company anticipates that the initiative will result in a reduction of cost and duration for clinical trials.
Evinova’s primary focus will be on introducing market established and scaled digital technology solutions already being used globally by AstraZeneca, to enhance the efficiency of clinical trial design…
